Menu Close

Experimental antibodies for Parkinson’s, Alzheimer’s may cause harmful inflammation

A team led by scientists at Scripps Research has made a discovery suggesting that experimental antibody therapies for Parkinson’s and Alzheimer’s have an unintended adverse effect—brain inflammation—that may have to be countered if these treatments are to work as intended.

Generated by Feedzy